<DOC>
	<DOCNO>NCT01748383</DOCNO>
	<brief_summary>The purpose study test hypothesis intracoronary transplantation autologous mononuclear CD 133 + bone marrow cell improve leave ventricular contractile function reduce combined end point primary STEMI ( mortality , recurrent myocardial infarction , angina , heart failure , stroke ) .</brief_summary>
	<brief_title>The Long-term Short-term Efficacy Safety Transplantation Autologous Bone Marrow Cells ( BMCs ) Patients With First STEMI ( ST Segment Elevation Myocardial Infarction )</brief_title>
	<detailed_description>The study randomize , open , control . 85 patient first STEMI enrol . Patients divide three group . On admission patient receive thrombolytic therapy 1,5 million U streptokinase . Transplantation autologous mononuclear bone marrow cell ( BMMCs ) аutologous CD133 + cell balloon catheter place infarct-related artery ( IRA ) perform stent implantation 28 patient patient ( 1st group ) 10 patient ( 2nd group ) 7-21 day STEMI . Another 47 patient ( 3nd group ) undergo stent implantation IRA day STEMI . Autologous BMMCs obtain bone marrow aspirate gradient centrifugation . Echocardiography , Holter monitoring perform . Plasma concentration pro-inflammatory anti-inflammatory cytokine ( IL1 , 6,8,10 ) , growth factor ( stem cell factor - SCF , vascular endothelial growth factor - VEGF , hepatocyte growth factor - HGF , fibroblast growth factor - FGF , insulin-like growth factor - IGF ) , number circulate CD34 +38- , CD133 + , СD117 + , CD90 +34- stem cell determine patient acute sub-acute myocardial infarction period . It go 7 year begin planned evaluate leave ventricular function patient , incidence cardiovascular end point ( death , recurrent myocardial infarction , angina , heart failure , stroke ) combination , evaluate safety transplantation autologous BMCs ( formation intra-myocardial tumor neoplastic process site ) 7 year begin study .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<criteria>18 year 75 Years Informed consent First STEMI Term admission intensive care unit first 24 hour onset Time reperfusion IRA earlier 4 hour initial onset acute transmural myocardial infarction Atrial fibrillation , permanent form Valvular heart disease Severe comorbidity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Bone marrow cell</keyword>
	<keyword>Acute myocardial infarction</keyword>
	<keyword>Transplantation autologous mononuclear</keyword>
	<keyword>Transplantation autologous CD133 + cell</keyword>
</DOC>